Development Level

Tchem 4 | 1,890
Tclin 2 | 602
Tbio 1 | 10,625

IMPC Phenotype

increased circulating calcium ... 1 | 32
preweaning lethality, complete... 1 | 633

Disease

psoriasis 7 | 6,685
Cancer 6 | 2,346
Inflammatory bowel disease 6 | 142
Kidney disease 6 | 397
tuberculosis 6 | 1,563
Alzheimer's disease 5 | 644
Crohn Disease 5 | 97
Dermatitis 5 | 141
Heart disease 5 | 279
Hyperalgesia 5 | 71
Hyperglycemia 5 | 120
Hypersensitivity reaction type II disease 5 | 235
Inflammation 5 | 109
Liver disease 5 | 219
Obesity 5 | 616
Reperfusion Injury 5 | 84
diabetes mellitus 5 | 1,663
periodontitis 5 | 269
ulcerative colitis 5 | 2,087
Acute kidney injury 4 | 65
Allergic hypersensitivity disease 4 | 123
Arthritis 4 | 248
Asthma 4 | 349
Atherosclerosis 4 | 275
Brain disease 4 | 84
Cerebrovascular disease 4 | 231
Chorioamnionitis 4 | 15
Colitis 4 | 46
Coronary artery disease 4 | 240
Diarrhea 4 | 155
Drug-Induced Liver Injury 4 | 118
Endometriosis 4 | 535
Gastritis 4 | 44
Heat Stroke 4 | 12
Hypertension 4 | 293
Influenza 4 | 142
Keratitis 4 | 42
Leishmaniasis 4 | 49
Lung Neoplasms 4 | 171
Malaria 4 | 140
Mastitis 4 | 48
Meningitis 4 | 46
Metabolic syndrome X 4 | 155
Multiple Sclerosis 4 | 498
Myocardial Ischemia 4 | 169
Neoplasm Invasiveness 4 | 127
Neoplasm Metastasis 4 | 138
Neuropathy 4 | 210
Pancreatitis 4 | 97
Peripheral Neuropathy 4 | 303
Peritonitis 4 | 37
Pneumonia 4 | 133
Prostatic Neoplasms 4 | 471
Rheumatoid Arthritis 4 | 1,170
Uveitis 4 | 103
cystic fibrosis 4 | 1,670
lung cancer 4 | 4,473
lung carcinoma 4 | 2,844
malignant mesothelioma 4 | 3,163
Anemia 3 | 252
Ankylosing spondylitis 3 | 138
Arthritis, Experimental 3 | 39
Autistic Disorder 3 | 320
Brain Ischemia 3 | 87
Candidiasis 3 | 48
Cardiomyopathies 3 | 90
Cholestasis 3 | 93
Chronic obstructive pulmonary disease 3 | 147
Collagen disease 3 | 25
Common cold 3 | 63
Dementia 3 | 129
Dermatitis, Allergic Contact 3 | 66
Dermatologic disorders 3 | 65
Diabetes Mellitus, Experimental 3 | 106
Diabetes Mellitus, Insulin-Dependent 3 | 77
Diabetic Retinopathy 3 | 53
Fatty liver disease 3 | 86
Glomerulonephritis 3 | 36
Hepatitis B 3 | 103
Hepatitis C 3 | 90
Hypercalcemia 3 | 37
Infertility 3 | 163
Leukopenia 3 | 42
Lipid metabolism disorder 3 | 102
Listeriosis 3 | 17
Liver Cirrhosis, Experimental 3 | 108
Lung disease 3 | 136
Mammary Neoplasms 3 | 410
Myopathy 3 | 128
Osteoporosis 3 | 259
Otitis media 3 | 32
Polycystic Ovary Syndrome 3 | 334
Primary immunodeficiency disease 3 | 52
Pulmonary Fibrosis 3 | 66
Respiratory Hypersensitivity 3 | 18
Sepsis 3 | 21
Thrombocytopenia 3 | 105
Toxic shock syndrome 3 | 28
Vasculitis 3 | 64
sarcoidosis 3 | 368

Tissue

Blood and immune system 7 | 17,994
Cardiovascular System 7 | 17,957
Digestive Tract 7 | 18,472
Endocrine System 7 | 18,511
Female tissues 7 | 18,646
Liver and Pancreas 7 | 18,135
Male tissues 7 | 17,968
Nervous System 7 | 18,560
Respiratory system 7 | 17,483
Skin and soft tissues 7 | 18,114
Urinary Tract 7 | 18,443

Target Family

Non-IDG 7 | 11,969

Grant Application

5R01AG023580-04 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interleukin-6 IL6 Tclin Non-IDG -4.47638 28484.7 1664
Interleukin-10 IL10 Tchem Non-IDG -4.07619 11514.6 1151
Interleukin-1 alpha IL1A Tchem Non-IDG -3.56384 3644.8 810
Tumor necrosis factor TNF Tclin Non-IDG -4.69357 50044.6 2261
Toll-like receptor 4 TLR4 Tchem Non-IDG -3.77330 6171.6 1142
Rho guanine nucleotide exchange factor 7 ARHGEF7 Tbio Non-IDG -2.13575 139.1 160
Insulin-like growth factor I IGF1 Tchem Non-IDG -4.31336 21900.3 689